Browsing by Author APOSTOLIDIS CHRISTOS

Showing results 21 to 40 of 57 < previous   next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2006JRC33597Cytotoxicity of PAI2, C595 and Herceptin Vectors Labeled with the Alpha-Emitting Radioisotope Bismuth-213 for Ovarian Cancer Cell Monolayers and ClustersSONG Y.j.; QU C.f.; RIZVI S.m.a.; LI Y.; ROBERTSON G.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; PERKINS A.c.; ALLEN Barry J.Articles in periodicals and books
2016JRC101407Dose escalation experience with Ac-225-PSMA-617 in PSMA targeting alpha-radiation therapy of patients with mCRPCKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN AlfredArticles in periodicals and books
2007JRC37757Electrochemical Behaviour of Neptunium in the Molten LiCL-KCl EuteticMASSET Patrick; APOSTOLIDIS CHRISTOS; KONINGS RUDY; MALMBECK RIKARD; REBIZANT JEAN; SERP JeromeArticles in periodicals and books
2007JRC37786An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha TherapyZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in periodicals and books
2018JRC109759In vitro evaluation of 225Ac-DOTA-Substance P for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA PILIP AGNIESZKA; RIUS MONTRAVETA MARIA; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; WEIS MIRJAM; BONELLI MILTON; LAURENZA MARTA; KROLICKI LESZEK; MORGENSTERN ALFREDArticles in periodicals and books
2006JRC35382In Vitro Screening for Synergism of High-linear Energy Transfer 213Bi-radiotherapy with other Therapeutic Agents for the Treatment of B-cell Chronic Lymphocytic LeukemiaVANDENBULCKE K.; THIERENS H.; VOS F.d.; OFFNER F.; JANSSENS F.; PHILIPPE J.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; BACHER K.; DE GELDER V., et alArticles in periodicals and books
2006JRC33757Interaction of Radiolabeled Antibodies with Fungal Cells and Components of Immune System In Vitro and During Radioimmunotherapy of Experimental Fungal InfectionDADACHOVA E.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; ZHANG T.; MOADEL T.; CASADEVALL A.Articles in periodicals and books
2007JRC41943Interim Analysis of Toxicity and Response in Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic MelanomaRAJA C.; GRAHAM P.; ABBAS RIZVI S. M.; SONG E.; GOLDSMITH H.; THOMPSON J.; BOSSERHOFF A.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; KEARSLEY J., et alArticles in periodicals and books
2005JRC33607Intralesional Targeted Alpha Therapy for Metastatic MelanomaALLEN Barry J.; RAJA C.; RIZVI S.m.a.; LI Y.; TSUI W.; GRAHAM P.; THOMPSON J.; REISFELD R.a.; KEARSLEY J.; MORGENSTERN ALFRED, et alArticles in periodicals and books
2006JRC34219Local Trageting of Malignant Gliomas by the Difussible Peptidic Vector DOTAGA-substance PKNEIFEL S.; CORDIER D.; GOOD S.; IONESCU M.; GHAFFARI A.; HOFER S.; KRETSCHMAR M.; TOLNAY M.; APOSTOLIDIS CHRISTOS; WASER B, et alArticles in periodicals and books
2005JRC30884Mechanisms of Cell Sensitization to Alpha-Radioimmunotherapy by Doxorubicin or Paclitaxel in MultipleMyeloma Cell LinesSUPIOT S.; GOUARD S.; CHARRIER J.; APOSTOLIDIS CHRISTOS; CHATAL J.-F.; BARBET J.; DAVODEAU F.; CHEREL M.Articles in periodicals and books
2007JRC38135Non-invasive Visualisation of the Development of Peritoneal Carcinomatosis and Tumour Regression After 213Bi-radioimmunotherapy Using Bioluminescence ImagingBUCHHORN H.m.; SEIDL C.; BECK R.; SAUR D.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2018JRC109704An overview of targeted alpha therapy with 225Actinium and 213BismuthMORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; KRATOCHWIL CLEMENS; SATHEKGE MIKE; KROLICKI LESZEK; BRUCHERTSEIFER FRANKArticles in periodicals and books
2007JRC41947Pharmacokinetics and toxicity of 213Bi-labeled PAI2 in Preclinical Targeted Alpha Therapy for CancerSONG E.; ABBAS RIZVI S. M.; QU C. F.; RAJA C.; BRECHBIEL M. W.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J.Articles in periodicals and books
2005JRC33606Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic CancerQU C.f.; SONG E.; LI Y.; RIZVI S.m.a.; RAJA C.; ROSS R; APOSTOLIDIS CHRISTOS; ALLEN Barry J.; MORGENSTERN ALFREDArticles in periodicals and books
2006JRC35141Preclinical Studies of Bismuth-213 Labeled Plasminogen Activator Inhibitor Type 2 (PAI2) in a Prostate Cancer Nude Mouse Xenograft ModelRIZVI S.m.a.; LI Y.; SONG E.; QU C.f.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B.j.Articles in periodicals and books
2005JRC30026Production of Ac-225 from Th-229 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MORGENSTERN ALFREDArticles in periodicals and books
2018JRC109738Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogueKROLICKI B; BRUCHERTSEIFER FRANK; KUNIKOWSKA JOLANTA; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK DARIUSZ; APOSTOLIDIS CHRISTOS; MIRZADEH SAED; ROLA R, et alArticles in periodicals and books
2017JRC106777PSMA-targeting alpha-Radiation therapy with 225Actinium-PSMA-617: Dosimetry, toxicity and duration of tumor-controlKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC105590Reduction Chemistry of Neptunium cyclopentadienide complexes: from structure to understandingDUTKIEWICZ MICHAL SEWERYN; APOSTOLIDIS CHRISTOS; WALTER OLAF; ARNOLD Polly L.Articles in periodicals and books